INFORMATION FOR
News
The FDA’s approval of Wegovy could help millions of Americans with both obesity and cardiovascular disease lower their risk of having a major cardiac event.
Two new studies showed a significant reduction in blood pressure in adults who underwent certain weight-loss treatments. YSPH's Dr. Harlan Krumholz says the studies provide robust evidence to support the concept that the effective treatment of obesity may be the key to improving overall heart health.
Doctors frequently rely on the electronic health record (EHR) when caring for patients. Oftentimes, EHR systems will include clinical decision support tools that offer recommendations and reminders for physicians determining how to manage diagnosis or treatment plans.
Those with the highest risk of heart disease are less likely to use apps and wearables that aim to help improve health.
Two in five U.S. adults with or at risk for heart disease use smartphones or tablets to monitor their health, a new Yale study finds
As wearable health devices grow more popular, there’s an opportunity to track the broader adult population’s heart health. But it’s much harder for smartwatches to accurately detect the heart’s electrical signals.
Wellbeing is considered a measurable and modifiable community attribute that study authors show is correlated with CV outcomes.
Less than a quarter US adults with or at risk for CVD wear a health and fitness tracker, and access to these technologies is uneven.
Wearable devices, such as those made by Apple and Fitbit, are becoming increasingly sophisticated in their ability to obtain electrocardiograms.
Adults 65 and over had the lowest likelihood of device use, despite this age group representing half of all adults with heart disease.
Few people with heart disease or risk factors for it use wearable devices.
A recent study in JAMA Network Open found that fewer than 1 in 4 people with or at risk for cardiovascular disease (CVD) use wearable devices, and only half of those who wear them do so consistently.
A new study reveals a staggering disparity in life expectancy between Black Americans and their white counterparts between 1999 and 2020.
Tariq Ahmad, MD, MPH, will present a late-breaking clinical trial during the 2023 European Society of Cardiology Heart Failure Association annual meeting.
Despite a decline from 2021, Covid killed more than 500 people per day, while heart disease and cancer deaths rose.
NIH-supported findings identify risk factors in women and suggest need for closer monitoring.
Sedentary time at an extraordinary level. Harlan Krumholz, MD , says we need a large-scale societal shift where daily movement is the norm.
Bempedoic acid lowers cholesterol, and a study found a modest effect on cardiac illness. But whether patients are any more willing to take it remains to be seen, experts said.
Men and women are encouraged to wear red to raise awareness about cardiovascular disease and help save lives.
Dr. Erica Spatz discusses sudden cardiac death.